fbpx

Written by 08:00 Analys

Cindrigo seizing global renewable power and baseload opportunities

With top level experience of international business development, power company management, national energy policy and governance, the experienced Cindrigo team is building a diversified player within renewable energy and cleantech power. Based on a rollout of geothermic power plants yielding about 20 MGBP per 20MW-plant and year, Cindrigo plans a rapid international expansion while also eyeing adjacent technologies. A successful rollout, with a first plant operational by 2023 and a total of +200 MW in 2026, justifies a probability weighted fair value range of 1.20-2.90 GBP per share in our DCF-valuation approach, while a peer multiple valuation of 12x EBIT and 10x EBITDA 2024 supports a fair value of 2.20-2.40 GBP per share. A value solely based on the initial Croatian rollout, whereas in the long term, the company plans an expansion to 1000MW over the next decade, which without considering execution risks, would make Cindrigo a multi-billion GBP-company.


Andreas Eriksson | 2022-04-11 08:00 | andreas@emergers.se 

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and Emergers is not subject to any prohibition on dealing ahead of the dissemination of investment research. This research does not constitute investment advice and is not a solicitation to buy shares. For more information, please refer to disclaimer.  
 
A renewable energy source for baseload power

As the need for reliable renewable power increases in line with the need for increased electrification to meet various climate accords, geothermal power has somewhat been forgotten compared to its sector colleagues wind and solar. With the acquisition of Energy Co-Invest Global (ECG), who owns a solid platform and a strong team within geothermal, Cindrigo looks to become a high roller within the renewable energy space with a base in geothermal power plants. Through running a very tight organization, where each project is set up in its own SPV (Special Purpose Vehicle) which will limit dilution of the Cindrigo share, the company can utilize its experience from managing projects to focus on plants where the technical competence is of importance and personnel intensity is low.

Synergies across high value subsidiaries

Through ECG, Cindrigo also retains a 48% ownership of Icelandic geothermal experts GEG Power ehf., that besides holding its own project portfolio is also an EPC-contractor that Cindrigo can utilize to construct most of their new geothermal plants, where a fair share of a geothermic project cost is EPC-related. We see a geothermal multi-plant rollout as a solid fundamental driver for revaluation. Cindrigo’s first projects has 60MW capacity power plants contrcted (with potential to expand to 200 MW) in Croatia through a 90/10-partnership, with an additional two sites licensed to construct geothermic power plants with a 20 MW capacity each.

Nearby cash flow a must to unleash full potential

Our forecast is based on a rollout of geothermic plants with a total of 218 MW production, with the first one operational in 2023. For the European plants we assume an annual yield of 20 MGBP and an EBITDA of 11.25 MGBP for each 20MW. With a 90% ownership, diluted by 35% for the first Croatian projects, we expect Cindrigo to re-invest future earnings and become less dependent of an external financier, and that is when we will see the full potential of the Cindrigo business model. Based on earlier assumptions we estimate Cindrigo will reach nearly 60 MGBP in sales in 2024 and over 150 MGBP in 2025. Based on a DCF valuation approach, where the NPV of future cashflows has been probability weighted in a range of 65-85%, we see support for a fair value range of 1.20-2.90 GBP per share, while a conservative (considering expected growth) peer valuation approach on 12x EBIT and 10x EBITDA 2024 supports a fair value range between 2.23 – 2.44 GBP per share. However, we also see significant risks associated with delays and execution, as well as the importance of getting plants up and running soon to reduce the dilution of a third-party financier.

DISCLAIMER

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers charges a standard fee for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.

Copyright: Copyright 2023 Incirrata AB (Emergers)

United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Read Less Read More

For new research on growth stocks, sign up to our newsletter